GlassScriptPhysician profile
William M Hansen
NPI 1932259488
$742.25
in general payments reported to CMS, 2019-2025
10 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.66 · 2020: $154 · 2021: $106 · 2022: $81.10 · 2023: $112 · 2024: $14.51 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $210.53 | 2020-2025 | Jublia, Bryhali |
| Sandoz INC. | $161.01 | 2019-2021 | |
| Depuy Synthes Sales INC. | $151.46 | 2025 | Tfn-Advance |
| Alfasigma USA, INC. | $90.11 | 2021-2022 | |
| Organogenesis INC. | $35.00 | 2022 | |
| Novo Nordisk INC | $22.66 | 2019 | |
| Mayne Pharma Commercial LLC | $20.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.00 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.62 | 2019 | |
| Merck Sharp & Dohme LLC | $14.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.